New functional activities for the p21 family of CDK inhibitors
about
Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance.The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionInvolvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progressionTOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinasePhosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle controlCDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanismsPim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cellsC-terminal phosphorylation controls the stability and function of p27kip1A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblastsNegative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1).Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrestAMP-activated kinase regulates cytoplasmic HuR.Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysisDeletion of the p27Kip1 gene restores normal development in cyclin D1-deficient micePCNA binding proteins in Drosophila melanogaster : the analysis of a conserved PCNA binding domainHuman HTm4 is a hematopoietic cell cycle regulatorRegulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1bPPARs and the cardiovascular systemRSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinasesCrystal structure of human CDK4 in complex with a D-type cyclinDown-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cellsPrimitive hematopoietic cells resist HIV-1 infection via p21Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancerGenetic alterations in pancreatic carcinomaDeregulation of p27 by oncogenic signaling and its prognostic significance in breast cancerThe role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cellsp16(INK4a) prevents centrosome dysfunction and genomic instability in primary cells.The structure of CDK4/cyclin D3 has implications for models of CDK activationExamination of the expanding pathways for the regulation of p21 expression and activity.Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell LeukemiaTargeting CDK4 and CDK6: From Discovery to TherapyReview on molecular and chemopreventive potential of nimbolide in cancer
P2860
Q21093282-293E0CA2-C592-4B2D-A937-2BBC6232B435Q21245733-EAD75D2B-35B3-4125-9606-2C88D03C033DQ22254222-5CCDC3EF-DF96-45DA-A4EF-7170377EECCBQ22254396-AA6E4C67-3395-4CA0-84FC-D8DBFE509465Q24297854-0D75281B-7EA2-4B76-91AA-E3EA492F4BC9Q24302257-CDB4CB44-8591-4B34-890D-566E0F32A9C5Q24304170-C494A613-521B-4985-966F-5FE5D7905626Q24307810-4530E696-9FFC-4D60-9062-E35773181AF7Q24530685-F29135D1-022D-495C-9DD8-481658B688D7Q24532054-0BA1BABF-8BB2-4329-B3BE-0C60D7B5BED0Q24534132-311B3BB0-8421-48F0-97F0-3EE275A5E0EDQ24537209-3D619A33-0DEF-4EB1-8ECB-2E9F6F22AF4FQ24537257-2A3C9DD2-573F-4C58-A61C-892194DBCF1FQ24537360-3A7C092F-DC58-4A65-AC19-498EA7226259Q24540051-5F2CDCC2-9BB3-4BF3-95C0-188A88556717Q24540387-F427B4D7-EB8B-427C-95F4-8A54D2BD2B91Q24545945-9EBB6978-CF6B-444E-8F2C-975BA7F26155Q24548219-40EC64A1-28F1-4D60-978D-CF2FBD4A7EC6Q24551162-5A3A79A1-80A0-444D-A925-66E101886C63Q24554609-3A6366E5-D7C9-4F3F-91F1-40F6A0521229Q24597148-00BD7B2D-6D6C-4965-8F1E-1A4EBB52F143Q24610494-89589477-A885-40B8-9E7E-8049E7DC3508Q24642728-7D56B674-0C19-4FCE-8432-DAF1B1A8B43FQ24647282-670FC04A-E650-42DF-B14C-061186A7FA1CQ24649057-D419AF53-6377-43D7-9BD6-28B6121B92ABQ24656160-5497B5DC-C5B1-4879-81A3-E79A0FFDACC3Q24672087-8063B72C-E92C-45E5-9181-6625C9424F33Q24681819-0AC34CCB-5318-4CFC-B755-0C83248B4C41Q24685138-C509B57D-D1E4-42E8-B2E0-A04FA7DA4942Q24793291-57AFDF09-4245-49B7-85CB-9F1FFED503BFQ24801465-EA2631A5-1EF2-4EA2-8AE2-A88AAE492296Q24803723-A6D10E6F-B78C-4A32-9F98-9FE434284403Q24807093-6F8DC935-6846-4B94-BA5D-10486E0E5E4EQ25255634-5138C027-12ED-4ABE-96FB-2E72B101306EQ27653913-48C7EF7F-9373-4B67-A3BF-0759A07E00CAQ27692024-82191A8C-3D15-4987-A664-901D8B1FB9B0Q27851564-F7BF74AB-52A6-48D4-98C6-B2A4C0C5BB89Q28081287-AF31DB2F-4E5C-49F2-B6E0-8363AE25884EQ28082912-B7697E9B-BCA2-4BFB-9F2E-D14138104FFAQ28082973-4CDD8781-B289-4BCC-ABAA-66983C38AC43
P2860
New functional activities for the p21 family of CDK inhibitors
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
New functional activities for the p21 family of CDK inhibitors
@ast
New functional activities for the p21 family of CDK inhibitors
@en
New functional activities for the p21 family of CDK inhibitors
@en-gb
New functional activities for the p21 family of CDK inhibitors
@nl
type
label
New functional activities for the p21 family of CDK inhibitors
@ast
New functional activities for the p21 family of CDK inhibitors
@en
New functional activities for the p21 family of CDK inhibitors
@en-gb
New functional activities for the p21 family of CDK inhibitors
@nl
prefLabel
New functional activities for the p21 family of CDK inhibitors
@ast
New functional activities for the p21 family of CDK inhibitors
@en
New functional activities for the p21 family of CDK inhibitors
@en-gb
New functional activities for the p21 family of CDK inhibitors
@nl
P2093
P3181
P356
P1433
P1476
New functional activities for the p21 family of CDK inhibitors
@en
P2093
J M Slingerland
L F Stevenson
M D Garrett
P304
P3181
P356
10.1101/GAD.11.7.847
P407
P577
1997-04-01T00:00:00Z